Literature DB >> 27030689

Heart Failure Readmission Reduction.

Joseph P Drozda1, Donna A Smith2, Paul C Freiman2, Janet Pursley1, Jeffrey A VanSlette3, Timothy R Smith1.   

Abstract

Little is known regarding effectiveness of readmission reduction programs over time. The Heart Failure Management Program (HFMP) of St. John's Physician Group Practice (PGP) Demonstration provided an opportunity to assess outcomes over an extended period. Data from an electronic health record, an inpatient database, a disease registry, and the Social Security Death Master File were analyzed for patients admitted with heart failure (HF) for 5 years before (Period 1) and 5 years after (Period 2) inception of PGP. HF admissions decreased (Period 1, 58.3/month; Period 2, 52.4/month, P = .007). Thirty-day all-cause readmission rate dropped from Period 1 (annual average 18.8% [668/3545]) to year 1 of Period 2 (16.9% [136/804], P = .04) and remained stable thereafter (annual average 16.8% [589/3503]). Thirty-day mortality rate was flat throughout. HFMP was associated with decreased readmissions, primarily related to outpatient case management, while mortality remained stable.

Entities:  

Keywords:  accountable care; disease management; heart failure; readmissions

Mesh:

Year:  2016        PMID: 27030689     DOI: 10.1177/1062860616637684

Source DB:  PubMed          Journal:  Am J Med Qual        ISSN: 1062-8606            Impact factor:   1.852


  2 in total

1.  Cardiology Consultation in the Emergency Department Reduces Re-hospitalizations for Low-Socioeconomic Patients with Acute Decompensated Heart Failure.

Authors:  Corey E Tabit; Mitchell J Coplan; Kirk T Spencer; Charina F Alcain; Thomas Spiegel; Adam S Vohra; Daniel Adelman; James K Liao; Rupa Mehta Sanghani
Journal:  Am J Med       Date:  2017-04-27       Impact factor: 4.965

2.  Diagnosis for readmission of senile patients hospitalized with acute decompensated heart failure in different departments: a retrospective cross-sectional study.

Authors:  Zhiying Zhao; Wenyan Wang; Jing Jin; Xuemei Liu
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.